Oramed Pharmaceuticals
ORMP
ORMP
47 hedge funds and large institutions have $16.3M invested in Oramed Pharmaceuticals in 2025 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 8 increasing their positions, 15 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
less capital invested
Capital invested by funds: $ → $
less ownership
Funds ownership: →
less funds holding
Funds holding: →
47% less repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 15
56% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 9
Holders
47
Holding in Top 10
1
Calls
$284K
Puts
–
Top Buyers
| 1 | +$196K | |
| 2 | +$141K | |
| 3 | +$58.1K | |
| 4 |
Mariner
Overland Park,
Kansas
|
+$22.7K |
| 5 |
Wealth Enhancement Advisory Services
Plymouth,
Minnesota
|
+$10.9K |
Top Sellers
| 1 | -$456K | |
| 2 | -$377K | |
| 3 | -$138K | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$116K |
| 5 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$88.6K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
NEWAS
51
N.E.W. Advisory Services
De Pere,
Wisconsin
| – |
|
|||
|
PCM
52
Prelude Capital Management
New York
| – |
|
|||
53
Simplex Trading
Chicago,
Illinois
| – |
|
|||
54
Group One Trading
Chicago,
Illinois
| – |
|
|||
|
FHA
55
First Horizon Advisors
Memphis,
Tennessee
| – |
|
|||
|
TRCT
56
Tower Research Capital (TRC)
New York
| – |
|